| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/09/2003 | CN1429110A Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 07/09/2003 | CN1429107A Compositions cotaining benzamide disulfide derivative for treating allergic diseases |
| 07/09/2003 | CN1429105A Dermal compositions containing coenzyme Q as active ingredient |
| 07/09/2003 | CN1429103A Novel process |
| 07/09/2003 | CN1429102A Hydrogel composition for transdermal drug delivery |
| 07/09/2003 | CN1429101A Stabilized aqueous suspensions for parenteral administration |
| 07/09/2003 | CN1429100A Improvements in or relating to delivery of oral drugs |
| 07/09/2003 | CN1429097A Use of ellagic acid as anti-pollution cosmetic agent |
| 07/09/2003 | CN1428165A Chinese medicine positioning preparation for curing ulcerative colitis |
| 07/09/2003 | CN1428163A Medicine bag for curing asthma |
| 07/09/2003 | CN1428157A Medicine for curing migraine |
| 07/09/2003 | CN1428144A Method for preparing mass micro-capsule |
| 07/09/2003 | CN1428143A Method for preparing micropill by using Chinese patent medicine extract and its pill-making machine |
| 07/09/2003 | CN1113912C Copolymers of carboxylic acids and multiply olefinically unsaturated carboxylic acid derivatives and their use as thickeners and dispergents |
| 07/09/2003 | CN1113780C Sealing machine for hard capsules |
| 07/09/2003 | CN1113675C Metered dose inhaler for fluticasone propionate |
| 07/09/2003 | CN1113657C Slow-releasing concentrated fish oil tablet and its preparation method |
| 07/09/2003 | CN1113650C Drug composition of self-emulsifying agent form lipophilic compounds |
| 07/09/2003 | CN1113649C Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations |
| 07/09/2003 | CN1113639C Preparing method and device for divisible tablets |
| 07/09/2003 | CN1113638C Method for producing coated tablets |
| 07/09/2003 | CN1113599C Antimicrobial treatment method for herpes simplex virus and other infectious diseases |
| 07/08/2003 | US6590059 Bioerodible polyorthoesters from dioxolane-based diketene acetals |
| 07/08/2003 | US6590043 Addition-condensation block copolymers having hydrophilic and hydrophobic segments that form micelles used for delivery of drugs such as antisense agents |
| 07/08/2003 | US6589999 Maintains pH values compatible with ocular administration; tolerance problems even with prolonged use does not occur |
| 07/08/2003 | US6589998 Administering biocompatible polymer in solvent |
| 07/08/2003 | US6589990 Topically administering to penis to treat sexual disorder |
| 07/08/2003 | US6589988 Pharmaceutical composition with antitumor activity on the basis of carboplatin |
| 07/08/2003 | US6589973 A clear, stable novel pharmaceutical preparation of selective cyclooxygenase II inhibitors (COX 2) inhibitors in the injection form for pain and inflammation |
| 07/08/2003 | US6589579 Production of particles for introduction into food using a stable microjet and a monodisperse aerosol formed when the microjet dissociates; functional foods |
| 07/08/2003 | US6589576 Includes xanthan gum which improves tolerance (e.g. less gastrointestinal symptoms such as emesis, stool patterns and gas) |
| 07/08/2003 | US6589572 Hypertension-treatment and cholesterol-depressant composition comprising extract from mixture of Panax notoginseng and Salvia miltiorrhiza and method of preparing the same |
| 07/08/2003 | US6589568 Therapeutic body lotion containing alkali metal hypohalite |
| 07/08/2003 | US6589563 Drug delivery system exhibiting permeability control |
| 07/08/2003 | US6589562 Multicomponent biodegradable bioadhesive controlled release system for oral care products |
| 07/08/2003 | US6589560 Stable glassy state powder formulations |
| 07/08/2003 | US6589559 Nasally administrable compositions |
| 07/08/2003 | US6589558 Photoablatable lenticular modulator |
| 07/08/2003 | US6589557 Porous celecoxib matrices and methods of manufacture thereof |
| 07/08/2003 | US6589556 For psychotropic, a gastrointestinal therapeutic or a migraine therapeutic; melts quickly in mouth of patient without requiring chewing; mouthfeel; binder, salivating agent, diluent/bulking agent, drug |
| 07/08/2003 | US6589555 Effervescence |
| 07/08/2003 | US6589554 Tablets quickly disintegrating in the oral cavity and process for producing the same |
| 07/08/2003 | US6589553 Controlled release oral dosage form |
| 07/08/2003 | US6589552 Microstructure grains; fine particle size |
| 07/08/2003 | US6589551 Chewable oral unit dosage |
| 07/08/2003 | US6589549 Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles |
| 07/08/2003 | US6589548 Controlled drug delivery system using the conjugation of drug to biodegradable polyester |
| 07/08/2003 | US6589547 Sustained-release preparation for AII antagonist, production and use thereof |
| 07/08/2003 | US6589546 Polymeric coatings for controlled delivery of active agents |
| 07/08/2003 | US6589543 Mixture containing clove oil, ginger oil, wintergreen oil, peppermint oil, ginger root powder, cayenne powder and petroleum jelly |
| 07/08/2003 | US6589536 Soft gelatin capsule manufacture |
| 07/08/2003 | US6589518 Mousse forming hair treatment composition |
| 07/08/2003 | US6589511 Biodegradable polymer, solvent, polyhydric alcohol, viscosi-fier and active ingredient; reaches all areas of periodontal pockets; high retention; maintaining high concentration for extended time |
| 07/08/2003 | US6589508 Methods and compositions for treating pulmonary disorders using optically pure (R,R) formoterol |
| 07/08/2003 | US6589507 Fast acting; chewable; acid binder, carbon dioxide efferves-cent compound, nonionic surfactant and swellable, gel forming polymer |
| 07/08/2003 | US6589229 Wearable, self-contained drug infusion device |
| 07/08/2003 | US6589225 Methods, systems, and kits for implanting articles |
| 07/08/2003 | CA2361954C Metered dose inhaler for albuterol |
| 07/08/2003 | CA2321232C Oral care compositions comprising chlorite and methods |
| 07/08/2003 | CA2269076C Preparation consisting of a surface-adhering, film-like or wafer-like administration form |
| 07/08/2003 | CA2254682C Method of treating eye infections with azithromycin |
| 07/08/2003 | CA2234426C Antibacterial composition for oral administration |
| 07/08/2003 | CA2213608C Pharmaceutical composition stabilized with a basic agent |
| 07/08/2003 | CA2163433C Multiparticulate pulsatile drug delivery system |
| 07/08/2003 | CA2142103C Submicron emulsions as ocular drug delivery vehicles |
| 07/08/2003 | CA2131553C Use of alkylureas and hydroxyurea as contraceptive agents |
| 07/08/2003 | CA2119610C Process for the preparation of a liposome dispersion under elevated pressure conditions |
| 07/08/2003 | CA2088300C Oil-in-water emulsions |
| 07/08/2003 | CA2059307C Bathing preparation |
| 07/03/2003 | WO2003054077A1 Cereal beta glucan compositions, methods of preparation and uses thereof |
| 07/03/2003 | WO2003053991A1 Pharmaceutical composition for the treatment of psoriasis and other skin diseases |
| 07/03/2003 | WO2003053907A1 Emollients and cosmetic compositions |
| 07/03/2003 | WO2003053896A1 METHOD FOR PRODUCING β MANNITOL DIRECTLY COMPRESSIBLE INTO TABLETS |
| 07/03/2003 | WO2003053565A1 Adsorbent for phosphoric acid |
| 07/03/2003 | WO2003053501A1 Metered dose inhaler |
| 07/03/2003 | WO2003053498A2 Medication delivery system and monitor |
| 07/03/2003 | WO2003053480A1 Composition for treating contact lenses in the eye |
| 07/03/2003 | WO2003053479A2 Composition for treating contact lenses |
| 07/03/2003 | WO2003053472A1 Eye drops |
| 07/03/2003 | WO2003053470A2 Pulsed bio-agent delivery systems based on degradable polymer solutions or hydrogels |
| 07/03/2003 | WO2003053465A2 Lyophilized preparation containing antibodies to the egf receptor |
| 07/03/2003 | WO2003053463A2 Poxvirus-containing compositions and process for their preparation |
| 07/03/2003 | WO2003053460A1 Crystalline compositions for controlling blood glucose |
| 07/03/2003 | WO2003053458A1 Use of a pharmaceutical composition containing epidermal growth factor (egf) for diabetic foot amputation prevention |
| 07/03/2003 | WO2003053453A1 Improvements in or relating to liquid, eye-instillable preparations comprising sodium hyaluronate |
| 07/03/2003 | WO2003053452A1 Heparin-containing ophthalmic agent |
| 07/03/2003 | WO2003053450A1 Ribavirin granulate for producing coated tablets |
| 07/03/2003 | WO2003053445A1 Use of desoxypeganine for treating clinical depression |
| 07/03/2003 | WO2003053442A1 Tempamine compositions and methods of use |
| 07/03/2003 | WO2003053436A1 Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 07/03/2003 | WO2003053432A1 5ht4 partial agonist pharmaceutical compositions |
| 07/03/2003 | WO2003053431A2 Pharmaceutical compositions based on azetidine derivatives |
| 07/03/2003 | WO2003053430A1 Drinkable preparation comprising ketoprofen and the use thereof in the simultaneous treatment of a group of animals for processes which are accompanied by fever, inflammation and/or pain |
| 07/03/2003 | WO2003053428A1 Controlled release dosage form having improved drug release properties |
| 07/03/2003 | WO2003053421A1 Gel compositions for external use, pad materials and pad materials to be packed in blister containers |
| 07/03/2003 | WO2003053420A1 Multiple-pulse extended release formulations of clindamycin |
| 07/03/2003 | WO2003053419A1 Coated tablets and process for producing the same |
| 07/03/2003 | WO2003053418A1 Ultrapure oral fludara formulation with a fast releasing active substance |
| 07/03/2003 | WO2003053417A2 Method for making a tablet comprising a morphine type analgesic and resulting tablet |
| 07/03/2003 | WO2003053416A1 Directly compressible formulations of azithromycin |